Intra-arterial | Before matched groups | After matched groups (1:3) | |||
---|---|---|---|---|---|
No intra-arterial | p value | No intra-arterial | p value | ||
Patients (n) | 26 | 123 | 78 | ||
Gender | 1.000 | 1.000 | |||
Female, n (%) | 4(15.4%) | 19(15.4%) | 10(12.8%) | ||
Male, n (%) | 22(84.6%) | 104(84.6%) | 68(87.2%) | ||
Age, yr, median (IQR) | 60.0(55.0–71.0) | 63.0(56.0–72.0) | 0.328 | 62.5(56.0–69.3) | 0.799 |
Body mass index (kg/m2) | 25.2 ± 3.12 | 24.1 ± 3.8 | 0.184 | 24.3 ± 3.1 | 0.202 |
Hypertension, n (%) | 12(46.2%) | 38(30.9%) | 0.134 | 27(34.6%) | 0.293 |
Diabetes, n (%) | 4(15.4%) | 16(13.0%) | 0.995 | 8(10.3%) | 0.723 |
Age-adjusted CCI | 4.0(3.0–7.0) | 4.0(3.0–5.0) | 0.625 | 4.0(3.0–6.0) | 0.909 |
ASA score | 2.0(1.8–2.0) | 2.0(2.0–2.0) | 0.221 | 2.0(2.0–2.0) | 0.188 |
ECOG PS | 1.0(0.0–1.0) | 1.0(0.0–1.0) | 0.490 | 1.0(1.0–1.0) | 0.394 |
Smoking history, n (%) | 15(57.7%) | 58(47.2%) | 0.329 | 40(51.3%) | 0.571 |
Time between confirmed tumor and RC, mo, median (IQR) | 3.0(1.0–6.8) | 5.0(1.0–18.0) | 0.133 | 5.0(1.0–18.0) | 0.173 |
TURBT before RC | 7(25.9%) | 57(46.3%) | 0.048 | 32(41.0%) | 0.100 |
Preoperative irradiation, n (%) | 0(0.0%) | 5(4.1%) | 0.587 | 3(3.8%) | 0.571 |
Follow-up length, mo, median (IQR) | 88.0(37.0–109.0) | 26.0(14.0–65.0) | 0.002 | 56.0(30.8–91.3) | 0.161 |